Topical Intra-Oral Ketoprofen for Migraine Prevention
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Intra-Oral Topical Ketoprofen gel, applied to a branch of the trigeminal nerve, has been
shown to prevent migraines when used once daily for 3 months in open label studies. This is a
randomized, double-blind, placebo controlled phase III prevention trial to determine safety
and efficacy.